Demand for Patient Positioning Systems and Impact of COVID-19……..
The global patient
positioning systems market
is anticipated to reach USD 1.4 billion
by 2025, according to a new report by Grand View Research, Inc.,
registering a 4.7% CAGR during the
forecast period. This market is expected to witness lucrative growth during
through 2025 owing to rising awareness about and surging expenditure on
diagnostic procedures. In addition, increasing prevalence of cancer and rising
geriatric population are expected to assist in market growth.
With Covid-19 infections rising globally, the
apprehension regarding a shortage of essential life-saving devices and other
essential medical supplies in order to prevent the spread of this pandemic and
provide optimum care to the infected also widens. In addition, till a
pharmacological treatment is developed, ventilators act as a vital treatment
preference for the COVID-19 patients, who may require critical care. Moreover,
there is an urgent need for a rapid acceleration in the manufacturing process
for a wide range of test-kits (antibody tests, self-administered, and others).
The report will account for Covid19 as a key market contributor.
According to the National Cancer
Institute, in 2016, there were 1,685,210 new cases of cancer diagnosed in U.S.
and 14.1 million cases globally. The most common types of cancer are breast
cancer, prostate cancer, and colon and rectum cancer. This steady increase in
disease prevalence acts as a driver for R&D investments in the industry.
Increase in innovation has resulted in improved efficiency and accuracy of
these systems in cancer therapy. These products keep patients immobile yet
comfortable during radiotherapy. This is anticipated to supplement industry
growth.
Rising expenditure on diagnostics
procedures has been a strong force driving demand in the market. According to a
research published by NCBI, majority oncologists and cardiologists in U.S. and
Germany prescribe diagnostics tests and choose a treatment plan only after
studying test results. Thus, demand for diagnostics tests is increasing
globally.
To Request Sample Copy of this report, click the link:
Further key findings from the study suggest:
·
By product, the tables segment
held a lucrative market share in 2016, owing to increasing prevalence of cancer
and rising number of surgeries performed
·
In terms of application, the
surgery segment is expected to account for the dominant market share on account
of rising incidence of cancer, globally
·
By end use, the ambulatory
segment is expected to register the highest growth over the forecast period
owning to increase in precision of minimally invasive technologies
·
North America is projected to
dominate the patient positioning systems market over the forecast period due to
presence of a large number of diagnostic centers
·
Some of the key players in the
patient positioning systems market are Medtronic; Hill-Rom Holdings, Inc.;
Stryker Corporation; Medline Industries; Skytron, LLC; OPT SurgiSystems Srl;
SchureMed; Smith & Nephew; STERIS plc; and Leoni.
The
global patient positioning systems market size was valued at USD 942.8 million
in 2016 and is expected to expand at a CAGR of 4.7% during the forecast period.
Growing geriatric population, increasing prevalence of cancer, rising awareness
among patient population, and surging expenditure on diagnostic procedures are
expected to boost the patient positioning systems market during the forecast
period.
Technological
advancements in sensors, such as optic fiber technology, cancer tracking
sensors, and MEMS sensors, is expected to fuel market growth. These systems
help keep patients in a comfortable and stable position during radiotherapy as
well as treatment delivery. The growth of this market is further supplemented
by increasing prevalence of cancer.
According
to the World Cancer Report published by the WHO, the prevalence of cancer is
estimated to reach 15 million new cases per year by 2020. The National Cancer
Institute estimated that 1,685,210 new cases of cancer may have been diagnosed
in 2016 in U.S. alone. This steady increase in disease prevalence acts as a
driver for R&D investment in the industry.
Increasing
awareness about and rising expenditure on diagnostic procedures is also
expected to increase the demand for patient positioning systems in the market.
According to the National Health Services (NHS), there were 42.1 million
diagnostics imaging tests performed in U.K. in the year 2016-2017. An increase
of 3.6% was recorded in the number of diagnostic imagining tests performed when
compared to the previous year. Additionally, there are many awareness campaigns
regarding early cancer diagnosis such as the National Awareness and Early
Diagnosis Initiative (NAEDI) in U.K. and Breast Cancer Now in U.S., which are
expected to increase the demand for diagnostic imaging procedures. This, in
turn, is expected to increase the demand for patient positioning systems.
Browse Press
Release of this report:
The
products analyzed in this study include tables and accessories. The tables
segment is expected to dominate the market owing to increased demand and rising
number of hospitals, ambulatory centers, and other settings such as specialty
centers and diagnostics centers.
The
tables segment is expected to retain its lead over the forecast period due to
rising demand for efficient and accurate diagnostic imaging, which is creating
growth opportunities for the segment.
The
accessories segment is expected to witness the fastest growth in the market,
owing to increasing number of patients undergoing different types of surgeries
and diagnoses. There is a greater demand for diagnosis in developing countries
such as India and China, which may drive sales of patient positioning systems
over the forecast period.
Based
on application, patient positioning systems are segmented into
diagnostics/imaging, surgery, and others. The surgery segment held the largest
share owing to increasing prevalence of chronic diseases such as cancer.
Additionally, there is an increase in healthcare expenditure globally. This is
anticipated to further supplement the growth of this application.
The
diagnostics segment is estimated to grow at a lucrative rate over the forecast
period, due to increasing expenditure on diagnostics/imaging, globally.Diagnostics
tests represent more than 3.0% of the total healthcare spending. These tests
also play a major role in a doctor’s decision-making process. Almost all cancer
diagnoses are based on laboratory tests and their results.
Grand View Research has segmented the
global patient positioning systems market on the basis of products,
application, end use:
Patient Positioning Systems Product Outlook (Revenue, USD
Million, 2014 - 2025)
·
Tables
·
Accessories
Patient Positioning Systems Application Outlook (Revenue,
USD Million, 2014 - 2025)
·
Surgery
·
Diagnostics
·
Other
Patient Positioning Systems End-use Outlook (Revenue, USD
Million, 2014 - 2025)
·
Hospital
·
Ambulatory Centers
·
Other
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Comments
Post a Comment